RESEARCHER PROFILE
Tamer M. Ibrahim
← Back to Kafrelsheikh University
T
Kafrelsheikh University
Tamer M. Ibrahim works in Synthesis and Characterization of Heterocyclic Compounds, Synthesis and biological activity, Computational Drug Discovery Methods, Research on Leishmaniasis Studies, SARS-CoV-2 and COVID-19 Research. Recorded institutional associations include Kafrelsheikh University, British University in Egypt, University of Freiburg.
74Publications
1,903Citations
28H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Evaluation and Optimization of Virtual Screening Workflows with DEKOIS 2.0 – A Public Library of Challenging Docking Benchmark Sets
2013 · 200 citationsInvestigation of the anti-inflammatory and analgesic activities of promising pyrazole derivative
2021 · 105 citationsLeishmania treatment and prevention: Natural and synthesized drugs
2018 · 98 citationsDesign, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors
2009 · 95 citations1,5-Diaryl-1,2,4-triazole Ureas as New SLC-0111 Analogues Endowed with Dual Carbonic Anhydrase and VEGFR-2 Inhibitory Activities
2023 · 74 citationsSynthesis, in silico experiments and biological evaluation of 1,3,4-trisubstituted pyrazole derivatives as antimalarial agents
2018 · 68 citationsIn silico identification of novel SARS-COV-2 2′-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches
2021 · 66 citationsDevelopment of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitors
2021 · 64 citationsGreen synthesis, antileishmanial activity evaluation, and in silico studies of new amino acid-coupled 1,2,4-triazoles
2018 · 56 citationsShooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones
2019 · 53 citationsDiscovery of indolinone-bearing benzenesulfonamides as new dual carbonic anhydrase and VEGFR-2 inhibitors possessing anticancer and pro-apoptotic properties
2023 · 50 citationsSynthesis, in vitro biological evaluation and in silico studies of certain arylnicotinic acids conjugated with aryl (thio)semicarbazides as a novel class of anti-leishmanial agents
2019 · 44 citationsSynthesis, anti-inflammatory screening, molecular docking, and COX-1,2/-5-LOX inhibition profile of some novel quinoline derivatives
2018 · 43 citationsDesign and synthesis of phthalazine-based compounds as potent anticancer agents with potential antiangiogenic activity via VEGFR-2 inhibition
2019 · 43 citationsApplying DEKOIS 2.0 in structure-based virtual screening to probe the impact of preparation procedures and score normalization
2015 · 40 citationsSupporting SARS-CoV-2 Papain-Like Protease Drug Discovery: In silico Methods and Benchmarking
2020 · 40 citationsNew antileishmanial quinoline linked isatin derivatives targeting DHFR-TS and PTR1: Design, synthesis, and molecular modeling studies
2022 · 40 citationsTetrahydrobenzo[h]quinoline derivatives as a novel chemotype for dual antileishmanial-antimalarial activity graced with antitubercular activity: Design, synthesis and biological evaluation
2023 · 38 citationsSynthesis, biological evaluation and modeling of hybrids from tetrahydro-1H-pyrazolo[3,4-b]quinolines as dual cholinestrase and COX-2 inhibitors
2020 · 36 citationsDesign and synthesis of 6-arylpyridine-tethered sulfonamides as novel selective inhibitors of carbonic anhydrase IX with promising antitumor features toward the human colorectal cancer
2023 · 36 citationsIdentification of novel piperazine-tethered phthalazines as selective CDK1 inhibitors endowed with in vitro anticancer activity toward the pancreatic cancer
2022 · 35 citationsDevelopment of Novel Quinoline-Based Sulfonamides as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors
2021 · 34 citationsSynthesis, Molecular Modeling and Biological Screening of Some Pyrazole Derivatives as Antileishmanial Agents
2018 · 33 citationsDesign, synthesis, biological evaluation and in silico studies of certain aryl sulfonyl hydrazones conjugated with 1,3-diaryl pyrazoles as potent metallo-β-lactamase inhibitors
2020 · 33 citationsSynthesis, biological evaluation and molecular modeling of novel thienopyrimidinone and triazolothienopyrimidinone derivatives as dual anti-inflammatory antimicrobial agents
2018 · 31 citations
